Empowering Caregivers Message Boards
  News Updates-Caregiving, Health Issues, Legislation & More
  800 New meds under study offer hope for Ill seniors and caregivers

Post New Topic  Post A Reply
profile | register | preferences | faq | search

UBBFriend: Email This Page to Someone! next newest topic | next oldest topic
Author Topic:   800 New meds under study offer hope for Ill seniors and caregivers
posted 08-28-2003 04:53 PM     Click Here to See the Profile for caringforothers     Edit/Delete Message
Here’s some optimistic news for seniors and their caregivers.

I’m pasting below a release about some 800 medicines now in development for various diseases possibly associated with aging. For more information on new medicines being tested, you can go to a free website at http://www.phrma.org.

And don’t forget indigent seniors may well qualify for free drugs from manufacturer patient assistance programs. You can go to another free website, http://www.helpingpatients.org, for this information.

For Immediate Release
Contacts: Jeff Trewhitt (202) 835-3464


A new survey by the Pharmaceutical Research and Manufacturers of America (PhRMA) found that drug companies are testing more than 800 potential medicines for diseases of aging, including 123 for heart disease and stroke, 395 for cancer and 309 for such debilitating diseases as Alzheimer’s, diabetes, and osteoporosis. All of the medicines are either in human clinical trials or awaiting approval by the Food and Drug Administration.

"The medicines in development offer hope of continuing and accelerating the remarkable improvements in the lives of seniors achieved over the past few decades," PhRMA President Alan F. Holmer said. He cited a study by Duke University researchers that found that chronic disability among the elderly was falling and that fewer seniors are going into nursing homes.

Alzheimer’s disease offers one example of the importance of stepped-up pharmaceutical research, Holmer said, noting that an estimated 14 million Americans will have Alzheimer’s disease by the middle of the 21st century unless a cure or prevention is found. Pharmaceutical companies are working on 18 potential treatments for Alzheimer’s disease, he added.

Eighteen of the medicines in development target depression, which affects one out of every five seniors, and 34 are aimed at diabetes, which costs the U.S. about $132 billion a year in direct medical expenses, lost productivity and disability. Seventeen of the medicines are for osteoporosis, a major health threat for an estimated 44 million Americans, and 15 target Parkinson’s disease – 60,000 new cases of which are diagnosed each year. Other medicines in development target bladder and kidney diseases, eye disorders, gastrointestinal disorders, osteoarthritis, pain, prostate disease, respiratory and lung diseases, rheumatoid arthritis and other conditions of aging.

"The promise of research underscores the need for prescription drug insurance coverage crafted in a way that gives seniors access to the medicines of today and provides incentives for companies to discover and develop the medicines of tomorrow," Holmer said.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading research-based pharmaceutical and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier and more productive lives. The industry invested an estimated $32 billion in 2002 in discovering and developing new medicines. PhRMA companies are leading the way in the search for new cures.
PhRMA Internet Address: http://www.phrma.org


All times are ET (US)

next newest topic | next oldest topic

Administrative Options: Close Topic | Archive/Move | Delete Topic
Post New Topic  Post A Reply
Hop to:

Contact Us | Empowering Caregivers

EMPOWERING CAREGIVERS� is trademarked. All Information on this website is under the umbrella of National Organization For Empowering Caregivers, INC.This includes but is not limited to the journal exercises, Newsletters and original articles, etc. Permission must be obtained from NOFEC by emailing info@nofec.org or telephoning 212.807.1204 for any external use of this material.

Powered by Infopop www.infopop.com © 2000
Ultimate Bulletin Board 5.47e